Cargando…
Polymyxins and Their Potential Next Generation as Therapeutic Antibiotics
The discovery of polymyxins, highly basic lipodecapeptides, was published independently by three laboratories in 1947. Their clinical use, however, was abandoned in the sixties because of nephrotoxicity and because better-tolerated drugs belonging to other antibiotic classes were discovered. Now pol...
Autor principal: | Vaara, Martti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671869/ https://www.ncbi.nlm.nih.gov/pubmed/31404242 http://dx.doi.org/10.3389/fmicb.2019.01689 |
Ejemplares similares
-
Corrigendum: Polymyxins and Their Potential Next Generation as Therapeutic Antibiotics
por: Vaara, Martti
Publicado: (2019) -
Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics
por: Vaara, Martti
Publicado: (2019) -
Excretion of the Polymyxin Derivative NAB739 in Murine Urine
por: Vaara, Martti, et al.
Publicado: (2020) -
Next-Generation Polymyxin Class of Antibiotics: A Ray of Hope Illuminating a Dark Road
por: Aslan, Abdullah Tarık, et al.
Publicado: (2022) -
New Dimensions of Research on Actinomycetes: Quest for Next Generation Antibiotics
por: Jose, Polpass Arul, et al.
Publicado: (2016)